Daisy Cooper MP: written questions
Daisy Cooper MP: full overview
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Written questions: dates and coverage
- Source checked
- 21 Nov 2026
- Last successful import
- 21 Nov 2026
- Records dated through
- 20 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 25,747 records in the source window 23 Aug 2026 to 21 Nov 2026. The published snapshot covers its stated source window. Answers and corrections can appear later; no indexed answer does not prove that none exists.
Understand written questions, dates and answers.
Read what this MP said, asked and contributed in Parliament.
56 published records · newest first.
Written questions
DiethylstilbestrolDepartment of Health and Social CareTabled 23 Jun 2026AnsweredUIN 12255More
Question: To ask the Secretary of State for Health and Social Care, what training healthcare professionals are given on the impacts of diethylstilbestrol.
Answer: I apologise and express my sincere sympathy to all those affected by exposure to diethylstilbestrol (DES), including those exposed in utero and their families.The Government’s focus is on carefully considering the available evidence and determining the mo...
Answered 29 Jun 2026
Original Parliament recordDiethylstilbestrol: Side EffectsDepartment of Health and Social CareTabled 23 Jun 2026AnsweredUIN 12254More
Question: To ask the Secretary of State for Health and Social Care, if he would hold a public inquiry into the effects of diethylstilbestrol.
Answer: I apologise and express my sincere sympathy to all those affected by exposure to diethylstilbestrol (DES), including those exposed in utero and their families.The Government’s focus is on carefully considering the available evidence and determining the mo...
Answered 29 Jun 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 16 Jun 2026AnsweredUIN 10228More
Question: To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of expanding eligibility for the MenB vaccination programme to students aged 26 and older.
Answer: On 12 June 2026, we announced a one-off, time-limited meningococcal group B (MenB) immunisation programme to protect those at highest immediate risk of MenB disease this autumn.People currently in the Year 13 age group in England and Wales, those born fro...
Answered 24 Jun 2026
Original Parliament recordLeukaemia: DiagnosisDepartment of Health and Social CareTabled 9 Jun 2026AnsweredUIN 8176More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of delays in access to Full Blood Count testing on the timely diagnosis of leukaemia.
Answer: The Government recognises that timely access to diagnostic tests is an important part of early and faster cancer diagnosis, including for blood cancers. The National Cancer Plan sets out the Government’s commitment to improve earlier diagnosis and faster ...
Answered 15 Jun 2026
Original Parliament recordBrain Cancer: Medical TreatmentsDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6497More
Question: To ask the Secretary of State for Health and Social Care, what recent discussions he has had with (a) MHRA and (b) NICE on OPTUNE treatment for brain cancer patients.
Answer: My Rt Hon. Friend, the Secretary of State for Health and Social Care, has had no recent discussions with the National Institute for Health and Care Excellence (NICE) or the Medicines and Healthcare products Regulatory Agency on the topic of OPTUNE, or Tum...
Answered 16 Jun 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6496More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the number of research clinicians supporting levels of brain tumour research.
Answer: The Department invests approximately £1.8 billion each year on research through the National Institute for Health and Care Research (NIHR).The NIHR is the United Kingdom’s largest funder of clinical academic training, delivering comprehensive research car...
Answered 9 Jun 2026
Original Parliament recordBrain: TumoursDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6495More
Question: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of access scanner capacity to support increased brain tumour research.
Answer: The Department invests approximately £1.8 billion each year on research through the National Institute for Health and Care Research (NIHR). The Department’s investment in the NIHR facilitates the direct funding of research projects through NIHR programmes...
Answered 9 Jun 2026
Original Parliament recordMedicine: ResearchDepartment of Health and Social CareTabled 3 Jun 2026AnsweredUIN 6494More
Question: To ask the Secretary of State for Health and Social Care, whether there will be measures to increase the recruitment and retention of clinicians to support medical research in the ten year workforce plan.
Answer: The 10-Year Health Plan committed to embedding research into everyday National Health Service care and increasing the skills and time for research within the workforce. The 10 Year Workforce Plan will put the NHS workforce on a sustainable footing so it c...
Answered 15 Jun 2026
Original Parliament recordPharmacy: FinanceDepartment of Health and Social CareTabled 1 Jun 2026AnsweredUIN 5398More
Question: To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of his department producing and publishing a long-term financial sustainability plan for community pharmacy in partnership with the communi
Answer: The Government recently announced a £340 million uplift to community pharmacy funding, a 10% increase, recognising the essential role pharmacies play in supporting patients and the wider National Health Service. This follows on from a 19% uplift delivered...
Answered 8 Jun 2026
Original Parliament recordBrain: InjuriesDepartment of Health and Social CareTabled 1 Jun 2026AnsweredUIN 5397More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to adopt the draft Acquired Brain Injury Action Plan, published on 4 May 2026, before 1 July 2026.
Answer: The Government recognises the significant and often life‑changing impact that acquired brain injury (ABI) can have on individuals and their families.The Department is currently working with NHS England and a range of stakeholders, including other Governme...
Answered 9 Jun 2026
Original Parliament recordBowel Cancer: Medical TreatmentsDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4573More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the equity of access to encorafenib with cetuximab treatments for bowel cancer between in England compared to (a) Scotland and (b) Wales.
Answer: Department officials have not had any discussions with the Medicines and Healthcare products Regulatory Agency or the National Institute for Health and Care Excellence (NICE) about expediting the licensing and evaluation of the BREAKWATER treatment.The BR...
Answered 4 Jun 2026
Original Parliament recordBowel Cancer: Medical TreatmentsDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4572More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) NICE and the (b) MHRA about expediting the licensing and evaluation of the BREAKWATER treatment for advanced bowel cancer in England.
Answer: Department officials have not had any discussions with the Medicines and Healthcare products Regulatory Agency or the National Institute for Health and Care Excellence (NICE) about expediting the licensing and evaluation of the BREAKWATER treatment.The BR...
Answered 4 Jun 2026
Original Parliament recordPrescriptionsDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4571More
Question: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 9 September 2025 to Question 71118 on Prescriptions: Occupational Therapy, if he will provide an update on the work of his department relating to the medicines respo
Answer: The Department supports expanding medicines responsibilities for non‑medical professionals where it is safe to do so. Appropriately trained occupational therapists can already supply and administer medicines under Patient Specific Directions or Patient Gr...
Answered 8 Jun 2026
Original Parliament recordCancer: VaccinationDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4392More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 May 2026 to Question 506 on Cancer: Vaccination, how many of those 15 companies were included in the 12 who attended the 2025 webinar.
Answer: The Cancer Vaccines Launch Pad (CVLP) is open to supporting immunotherapy trials for all cancer types, including brain cancer, and welcomes conversations with interested companies.NHS England hosted a webinar in 2025, and representatives from 12 pharmaceu...
Answered 4 Jun 2026
Original Parliament recordCancer: VaccinationDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4391More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 May 2026 to Question 506 on Cancer: Vaccination, whether there will be further (a) webinars and (b) other engagement events for interested pharmaceutical companies in 2
Answer: The Cancer Vaccines Launch Pad (CVLP) is open to supporting immunotherapy trials for all cancer types, including brain cancer, and welcomes conversations with interested companies.NHS England hosted a webinar in 2025, and representatives from 12 pharmaceu...
Answered 4 Jun 2026
Original Parliament recordBrain Cancer: VaccinationDepartment of Health and Social CareTabled 29 May 2026AnsweredUIN 4390More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 22 May 2026 to Question 506 on Cancer: Vaccination, whether those 15 companies have an interest in brain cancer vaccines.
Answer: The Cancer Vaccines Launch Pad (CVLP) is open to supporting immunotherapy trials for all cancer types, including brain cancer, and welcomes conversations with interested companies.NHS England hosted a webinar in 2025, and representatives from 12 pharmaceu...
Answered 4 Jun 2026
Original Parliament recordHealth Professions: RecruitmentDepartment of Health and Social CareTabled 14 May 2026AnsweredUIN 1243More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the availability of jobs for newly qualified (a) nurses, (b) doctors and (c) other medical professionals.
Answer: We will publish a 10 Year Workforce Plan to set out action to create a workforce ready to deliver the transformed services set out in the 10-Year Health Plan.The 10 Year Workforce Plan will ensure the National Health Service has the right people in the ri...
Answered 1 Jun 2026
Original Parliament recordCancer: VaccinationDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 506More
Question: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 14 April 2026 to Question 127101 on Cancer: Vaccination, (a) (i) how many and (ii) which pharmaceutical companies attended the NHS England webinar in 2025, and (b) (
Answer: The Cancer Vaccine Launch Pad (CVLP) is a platform that is increasing access and speeding up recruitment to clinical trials for personalised cancer vaccines and other immunotherapies for patients who have been diagnosed with cancer. In 2025, the scope of ...
Answered 22 May 2026
Original Parliament recordDoctors: Sexual OffencesDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 499More
Question: To ask the Secretary of State for Health and Social Care, if he will take legislative steps to end the five year rule on investigating sexual misconduct cases before the House rises for summer recess.
Answer: The Government is committed to modernising the regulation of all healthcare professionals in the United Kingdom.As a first step, on 24 March 2026, we published our Reforming the General Medical Council legislative framework consultation, which sets out pr...
Answered 20 May 2026
Original Parliament recordPsychiatric Hospitals: HertfordshireDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 498More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of acute mental health inpatient places in Hertfordshire.
Answer: Since the pandemic, mental health services in Hertfordshire have faced sustained pressure, including a reliance on out‑of‑area beds, reflecting national trends. A 2023/24 review found local inpatient capacity was significantly below comparable areas.In re...
Answered 30 Jun 2026
Original Parliament recordWatford HospitalDepartment of Health and Social CareTabled 13 May 2026AnsweredUIN 497More
Question: To ask the Secretary of State for Health and Social Care, if he will bring forward from 2032 the New Hospital Programme construction work to redevelop Watford General hospital should capacity become available.
Answer: Watford General Hospital is part of Wave 2 of the New Hospital Programme, as set out in the published Plan for Implementation. Pre-construction activity, which includes business case development and enabling works, is expected to commence from 2028, with ...
Answered 18 May 2026
Original Parliament recordCancer: VaccinationDepartment of Health and Social CareTabled 14 Apr 2026AnsweredUIN 127101More
Question: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 30 March to Question 119469 on Cancer: Vaccination, how many pharmaceutical companies have been contacted by his Department with details of the expansion of eligibility of
Answer: The Cancer Vaccine Launch Pad (CVLP) is a platform that is increasing access and speeding up recruitment to clinical trials for personalised cancer vaccines and other immunotherapies for patients who have been diagnosed with cancer. In 2025, the scope of ...
Answered 24 Apr 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 25 Mar 2026AnsweredUIN 123726More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the cost-effectiveness of commissioning a MenB vaccination programme through community pharmacy.
Answer: The Government is looking to expand the number of vaccines offered in community pharmacies across the country through local, targeted vaccination programmes. This has already started with NHS England commissioning some community pharmacies in the Midlands...
Answered 20 Apr 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 25 Mar 2026AnsweredUIN 123725More
Question: To ask the Secretary of State for Health and Social Care, whether his Department would consider commissioning MenB vaccination programmes through community pharmacy.
Answer: The Government is looking to expand the number of vaccines offered in community pharmacies across the country through local, targeted vaccination programmes. This has already started with NHS England commissioning some community pharmacies in the Midlands...
Answered 20 Apr 2026
Original Parliament recordMeningitis: VaccinationDepartment of Health and Social CareTabled 25 Mar 2026AnsweredUIN 123724More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the role community pharmacy could play in providing a MenB vaccine catch-up service to students and young people at risk.
Answer: The Government is looking to expand the number of vaccines offered in community pharmacies across the country through local, targeted vaccination programmes. This has already started with NHS England commissioning some community pharmacies in the Midlands...
Answered 20 Apr 2026
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →